Proteq West Nile 2x1 dose

Boehringer Ingelheim
Expiry date:
Registration number:
NL: REG NL 107618

Is the registration number of your country not listed? Then this product falls within the cascade control system.

Active immunisation against West Nile virus.
More info

Disclaimer: Product in the photo may differ from the actual product.

Proteq West Nile 2x1 dose + syringe

Suspension for injection containing West Nile recombinant canarypox virus (vCP2017). 

The vaccine strain vCP2017 is a recombinant canarypox virus expressing the preM/E genes of West Nile virus. After inoculation, the virus does not multiply in the horse but expresses the protective proteins. As a consequence, these proteins induce protective immunity against equine West Nile disease.

Active immunisation of horses from 5 months of age against West Nile disease. Proteq West Nile reduces the number of viraemic horses. If clinical signs are present, their duration and severity are reduced. 
Onset of immunity: 4 weeks after the first dose of the primary vaccination course. In order to achieve full protection, the full vaccination course of two doses must be given.  

Duration of immunity: 1 year after a full primary vaccination course of two injections.

Route of administation and dosage
For intramuscular use.
Shake gently before use. 

Administer one dose of 1ml, by intramuscular injection, preferably in the neck region, according to the following schedule:
- Primary vaccination course: first injection from 5 months of age, second injection 4-6 weeks later
- Revaccination: a sufficient degree of protection should be achieved after an annual booster injection with a single dose although this schedule has not been fully validated.

© 2023 Grovet B.V. All rights reserved.